Novo Nordisk
Q2 2022 Earnings Call
Aug 03, 2022, 1:30 p.m. ET
Contents:
- Prepared Remarks
- Questions and Answers
- Call Participants
Prepared Remarks:
Operator
Good evening. This is the conference operator. Welcome, and thank you for joining the second quarter 2022 Novo Nordisk earnings conference call. [Operator instructions] At this time, I would like to turn the conference over to Mr.
Lars Fruergaard Jorgensen, CEO of Novo Nordisk. Please go ahead, sir.
Lars Fruergaard Jorgensen -- President and Chief Executive Officer
Welcome to this Novo Nordisk earnings call for the first six months of 2022 and the outlook for the year. This call follows the early announcement and raised guidance published today. Due to Danish securities regulation, we advanced the release that was originally scheduled for tomorrow morning. bMy name is Lars Fruergaard Jorgensen, and I'm the CEO of Novo Nordisk.
With me today, I have executive vice president and head of commercial strategy and corporate affairs, Camilla Sylvest; executive vice president and head of North America operations, Doug Langa; executive vice president and head of development, Martin Holst Lange; and finally, chief financial officer, Karsten Munk Knudsen. All of us will be available for the Q&A session. Today's announcement and the slides for this call are available on our website, novonordisk.com. Please note that this call is being webcast live and a recording will be made available on our website as well.
This call is scheduled to last for one hour. Please turn to the next slide. The presentation is structured as outlined on slide two. Please note that all sales and operating profit growth statements will be at constant exchange rates unless otherwise specified.
The Q&A session will begin in about 25 minutes. Please turn to slide three. As always, I need to advise you that this call will contain forward-looking statements. Such are subject to risks and uncertainties that could cause actual results to differ materially from expectations.
For further information on the risk factors, please see the company announcement for the first six months of 2022 as well as the slides prepared for this presentation. Please turn to the next slide. In the first six months of 2022, we delivered double-digit sales and operating profit growth, which has enabled us to raise our outlook for the full year. I'd like to start this call by going through the performance highlights across our strategic aspirations before handing over to -- the word to my colleagues.